Trump administration reportedly plans to link autism to Tylenol use during pregnancy

Market & Industry Trends - The Trump administration is reportedly planning to link Tylenol use during pregnancy to autism [1] - Autism rates in the US have increased significantly, affecting 1 in 31 children in 2022, up from 1 in 150 in 2000 [2] - Conflicting data exists regarding the link between Tylenol use and autism risk, with some studies suggesting a connection and others, controlling for genetics, finding no association [3] Company Performance & Stock Impact - Kenview shares are under pressure due to the reported link between Tylenol and autism [1] - Kenview stock was down approximately 7% on the day of the report and about 25% year-to-date [5] - Kenview strongly disagrees with any suggestion that acetaminophen causes autism, citing independent sound science [5] Regulatory & Public Health Implications - The administration may suggest pregnant women only take Tylenol for fevers, given the risks associated with fever during pregnancy [4] - Tylenol is the only pain reliever generally considered safe for use during pregnancy, making any recommendations potentially impactful [4]